In this study, the deformation behaviour of metastable β-type Ti-33Nb-4Sn alloys in different thermo-mechanical treatment states is investigated by tensile tests and in situ synchrotron X-ray diffraction (SXRD). In the case of solution-treated alloy, stress-induced martensitic (SIM) transformation takes place over a wide strain range of 0.5-14%. During this SIM transformation, the parameter of b α" ([020] α") increases with macroscopic strain within strain range of 1.5-4.7%, giving rise to that the α" variants, with b α"-axis ([020] α") parallel to tensile direction, are formed preferentially to accommodate the macroscopic strain during loading. Similar SIM transformation behaviour also occurs in cold-rolled alloy with the exception that the extent of SIM
In this study, the stress-induced martensitic (SIM) transformation of a recently developed metastable β-type Ti-33Nb-4Sn alloy consisting of a mixture of β and α" phases are investigated by in situ synchrotron X-ray diffraction (SXRD). It is shown that though the SIM transformation covers a wide strain range, some remaining β phase is still observed after loading, indicating that the SIM transformation is incomplete. During SIM, the parameter of bα" increases with macroscopic strain within the strain range of 1.5-4.7%, while the parameters of aα" ([100]α") and cα" ([002]α") remain constant or decrease with increasing strain, respectively. This provides a plausible explanation for why the (020)α" peak intensifies, but the (002)α" peak decreases and even eliminates in the loading direction during loading. Additionally, the activation sequence of different deformation mechanisms is clarified unambiguously.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.